Loading
Latest filing published 22 Sept 2026 for Legend Biotech Corp, €1.1M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Huang Ying in Legend Biotech Corp. In total, 2 filings cover trades dated from 26 June 2026 to 22 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 22 September 2026, the filings show a transaction worth €1.1M in Legend Biotech Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations